Mitochondria‐specific antioxidant MitoTEMPO alleviates senescence of bone marrow mesenchymal stem cells in ovariectomized rats
Journal of Cellular Physiology · 2024-08 · 239 (8)
DOI: 10.1002/jcp.31323 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Physiology, online erschienen am 27.05.2024. Verfasst von Jiayi Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Surgery, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Mitochondria, Ovariectomy, Cellular Senescence. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, dominant disease biological sample project of the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine.
Abstract (Originalsprache)
Senescence in bone marrow mesenchymal stem cells (BMSCs), triggered by excessive oxidative stress, plays a crucial role in the onset of postmenopausal osteoporosis. Recent studies underscore the importance of mitochondrial rehabilitation and quality control as key determinants in the modulation of oxidative stress and cellular senescence. MitoTEMPO, a mitochondria‐targeted antioxidant, has been shown to mitigate the heightened levels of reactive oxygen species (ROS). In our research, we observed that BMSCs from ovariectomized (OVX) rats displayed premature senescence, which was attributed to combined mitochondrial and lysosomal dysfunction, a condition that worsens with extended estrogen deprivation. Treatment with MitoTEMPO effectively reversed these effects, reinstating lysosomal functionality and suppressing the mitochondrial unfolded protein response (UPRmt). Subsequent in vivo experiments corroborated these observations, revealing that MitoTEMPO administration in OVX rats curtailed trabecular bone loss and reduced the expression of p53, HSP60, and CLPP in the trabecular bone region of the proximal tibia. Overall, our findings suggest that MitoTEMPO holds promise as a therapeutic agent to counteract senescence in OVX‐BMSCs, offering a potential strategy for treating postmenopausal osteoporosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral Surgery, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
ORCID-Profile: Jiayi Li, Yuxin Zhang
Förderung
- National Natural Science Foundation of China
- dominant disease biological sample project of the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Zitieren
APA
Li, J., Zhang, D., Zhang, Y., Ge, J., & Yang, C. (2024). Mitochondria‐specific antioxidant MitoTEMPO alleviates senescence of bone marrow mesenchymal stem cells in ovariectomized rats. Journal of Cellular Physiology, 239(8). https://doi.org/10.1002/jcp.31323
Vancouver
Li J, Zhang D, Zhang Y, Ge J, Yang C. Mitochondria‐specific antioxidant MitoTEMPO alleviates senescence of bone marrow mesenchymal stem cells in ovariectomized rats. Journal of Cellular Physiology. 2024;239(8). doi:10.1002/jcp.31323
BibTeX
@article{Li2024,
author = {Li, Jiayi and Zhang, Dahe and Zhang, Yuxin and Ge, Jing and Yang, Chi},
title = {Mitochondria‐specific antioxidant MitoTEMPO alleviates senescence of bone marrow mesenchymal stem cells in ovariectomized rats},
journal = {Journal of Cellular Physiology},
year = {2024},
volume = {239},
number = {8},
doi = {10.1002/jcp.31323}
}
EUVIMED